![CME Programme CSHK mw_menu_data_5564_56eb2b174e5e3.jpg](https://cshk.org/site/CSHK/upload/mw_menu_data/file/mw_menu_data_5564_56eb2b174e5e3.jpg)
CME Programme
-
Non-Regular Activities
CME Hybrid Symposium on Diabetes Mellitus & Heart Failure - 1) SGLT2 Inhibition: Latest Evidence along the Cardio-renal-metabolic Axis 2) SGLT2 Inhibition across LVEF Spectrum: The Turning Point in HF HistoryDate: 10/06/2023 Enquiries: CME Department, The Hong Kong Medical Association CME Points Awarded: 2 points